There are a variety of physician preferences for following tumors during therapy, but the approach used in most clinical trials is a standard CT scan every other cycle of chemotherapy. There is increasing use of PET scanning, but this is experimental, expensive, and there is a high risk of getting misleading information from a PET that could result in inappropriate changes in therapy.
murray (Friend) voted for answer by DavidCarboneMDPhD (Physician - Oncology - Hematology/Oncology (Verified))
Call SHARE at: 866-891-2392
to speak directly to a trained breast cancer survivor for support and guidance.
3 Quick Ways You Can Help
1) Spread the word! Tell people you think might want some support. Tell medical professionals, health providers, and organizations.
2) Like us on Facebook and follow us on Twitter! 3) Volunteer - email us at volunteer@talkabouthealth.com for more information.
Note: Usernames have been made anonymous and profile images are not shown to protect the privacy of our members.